In This Article:
SASKATOON, Saskatchewan, May 07, 2024--(BUSINESS WIRE)--ZYUS Life Sciences Corporation ("ZYUS" or the "Company") (TSXV: ZYUS) today announces that, further to the Company’s press release dated April 29, 2024, the Company’s audited annual financial statements, the related management’s discussion and analysis, and the accompanying chief executive officer and chief financial officer certification for its financial year ended December 31, 2023 (the "Annual Filings) have now been released and filed under the Company’s profile on SEDAR+ at www.sedarplus.ca.
While preparation of Annual Filings took longer than expected due to accounting for various complex accounting matters, including the Company’s reverse takeover transaction of Phoenix Canada Oil Company Limited and completion of additional audit procedures required to be performed, the Company believes those matters to have been addressed to the extent relevant to future periods.
About ZYUS Life Sciences Corporation
ZYUS (TSXV: ZYUS) is a life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management. Through rigorous scientific exploration and clinical research, ZYUS aims to secure intellectual property protection, safeguarding its innovative therapies and bolstering shareholder value. ZYUS’ unwavering commitment extends to obtaining regulatory approval of non-opioid-based pharmaceutical solutions, in pursuit of transformational impact on patients’ lives. For additional information, visit www.zyus.com or follow us on X (formerly known as Twitter) @ZYUSCorp.
Cautionary Statement Regarding Forward Looking Information
Information and statements contained in this news release that are not historical facts are "forward-looking information" within the meaning of applicable securities legislation that involve risks and uncertainties relating, but not limited, to ZYUS’ current expectations, intentions, plans, and beliefs. Forward-looking information can often be identified by forward-looking words such as "anticipate", "believe", "expect", "goal", "plan", "target", "intend", "estimate", "could", "should", "may" and "will" or the negative of these terms or similar words suggesting future outcomes, or other expectations, beliefs, plans, objectives, assumptions, intentions or statements about future events or performance. Examples of forward-looking information in this news release include, without limitation, that certain accounting matters to have been addressed to the extent relevant to future periods. This forward-looking information is based, in part, on assumptions and factors that may change or prove to be incorrect, thus causing actual results, performance or achievements to be materially different from those expressed or implied by forward-looking information.